logo-loader
NASDAQ:ARGS

Argos Therapeutics Inc

Receive alerts
Market:
NASDAQ
Market Cap:
-
Price
-
Change
-
52 weeks high
-
52 weeks low
-

In brief

Argos Therapeutics is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases based on its Arcelis™ technology platform. Using biological components from each patient, Arcelis-based immunotherapies employ the patient´s dendritic cells to activate an immune response specific to the patient´s disease. Argos´ most advanced product candidates include AGS-003 for the treatment of metastatic renal cell carcinoma, or mRCC, and AGS-004 for the treatment of HIV.